Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Collaboration: Page 2
King's College London, bit.bio collaboration launched to build multicell brain models
By
Matt Limb
A collaboration has been launched in the U.K. to build multicell models of the human brain deemed vital to develop novel therapies for neuronal and psychiatric disorders.
December 5, 2023
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
By
Matt Limb
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Genomics England, Oxford Nanopore to collaborate on sequencing rare diseases
By
Matt Limb
Genomics England and Oxford Nanopore Technologies have announced a strategic research partnership to resolve undiagnosed rare disease cases.
November 7, 2023
Pharma companies back project to create largest African ancestry genomics research database
By
Nick Paul Taylor
AstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.
October 25, 2023
Oxford Nanopore to receive $84.6M investment from BioMĂ©rieux, enters collaboration with Mayo Clinic
By
LabPulse.com staff writers
Oxford Nanopore is receiving a strategic investment of 70 million pounds ($84.6 million) from in vitro diagnostics (IVD) company BioMĂ©rieux. In addition, the firm has entered a collaboration with the Mayo Clinic on test development.
October 19, 2023
ARUP launches new collaborative research institute
By
Matt Limb
ARUP Industries is hoping to “push the boundaries of diagnostic medicine” via the launch of a new research institute that aims to forge collaborations with industry and community partners.
October 18, 2023
AI-driven method developed to identify therapeutic targets
By
Matt Limb
Researchers have developed a method of identifying therapeutic targets for human diseases associated with protein phase separation that they say could be used to discover targets for Alzheimer’s and other neurogenerative diseases.
October 17, 2023
Twist Bioscience, Bayer enter agreement on antibody discovery and licensing
By
LabPulse.com staff writers
Twist Bioscience and Bayer have signed an antibody discovery, option, and licensing agreement.
October 9, 2023
Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer
By
LabPulse.com staff writers
Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.
September 18, 2023
Navigate BioPharma, Becton Dickinson collaborate on CDx solutions
By
LabPulse.com staff writers
Navigate BioPharma and Becton Dickinson have formed a strategic collaboration to use flow cytometry to develop and commercialize companion diagnostics (CDx) and clinical decision-making solutions.
September 11, 2023
TScan teams with Tempus to develop companion diagnostic for cancer cell therapy
By
Nick Paul Taylor
The biotech firm TScan has identified Tempus as a company that can help it select the right treatments for patients. Tempus is the developer of xT CDx, a companion diagnostic that the FDA approved earlier this year.
July 11, 2023
Lunit, Japan national cancer center collaborate on AI-based pathology for oncology
By
LabPulse.com staff writers
In collaborative studies with the national cancer center, researchers are evaluating the potential of the Lunit Scope artificial intelligence biomarker platform to predict clinical outcomes for rectal cancer.
May 30, 2023
Previous Page
Page 2 of 7
Next Page